If you struggle with treatment-resistant depression, there’s a different choice to turn to.
What is SPRAVATO® (esketamine) nasal spray?
SPRAVATO® nasal spray is an FDA-approved prescription nasal spray used in conjunction with oral antidepressants. This treatment is for adults with treatment-resistant depression. Esketamine is administered in a treatment center under the supervision of a healthcare provider.
Those who took Esketamie Nasal Spray experienced greater reductions in depression symptoms at four weeks compared to those who received a placebo plus an oral antidepressant.
SPRAVATO® is covered by most insurances, please contact our office to discuss your plan.
For more information, please visit the SPRAVATO® website or contact our office.
